April 2020 - Page 2 of 2

ThermoGenesis, a Major Shareholder of Immunecyte, Announces that it has Notified the FDA of its Intent to Distribute the Company’s Rapid COVID-19 Point-of-Care Test Kit

by Immunecyte | Apr 3, 2020 | Latst News

RANCHO CORDOVA, Calif., March 31, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a major shareholder of Immunecyte, a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that it has notified the U.S....

Next Entries »

ThermoGenesis, a Major Shareholder of Immunecyte, Announces that it has Notified the FDA of its Intent to Distribute the Company’s Rapid COVID-19 Point-of-Care Test Kit

Recent Posts

Recent Comments

Archives

Categories